Bali Muralidhar - Profile and Investment Details

Investor Profile

Bali Muralidhar is a Venture Capital, Private Equity Firm, Investor based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin, CRISPR Therapeutics, Attenua, Broncus Technologies, Jasper Therapeutics, Synosia Therapeutics, X4 Pharmaceuticals, Kspine, Anjarium Biosciences, Zogenix, PrimeraDx (Primera Biosystems), Scorpion Therapeutics, Avila Therapeutics, Personalis, MD On-Line, GenSight Biologics, Dicerna Pharmaceuticals, Verona Pharma, Micromet, Proteon Therapeutics, Prosensa, Glycomine, Stanmore Implants Worldwide, GTx, Median TechnologiesValeritas, Soleno Therapeutics, Wilson Therapeutics, Chroma Therapeutics, Avillion, Hydra Biosciences, Algeta, Sientra, Intellikine, Chiasma, British Business Bank, Gynesonics, Reneo Pharmaceuticals, Vera Therapeutics, Portola Pharmaceuticals, Nouscom, Vaxcyte, Lombard Medical plc, NuCana BioMed, Labcyte, Pathwork Diagnostics, Onbone, Senseonics, Novexel, Clovis Oncology, Atsena Therapeutics, Cytos, VirionHealth, Phathom Pharmaceuticals, Fovea Pharmaceuticals, Venatorx Pharmaceuticals, IS Pharma, Effector Therapeutics, Wugen, Sonitus Medical, Paratek Pharmaceuticals, Q32 Bio, GammaDelta Therapeutics, Tizona Therapeutics, Oxagen, SFJ Pharmaceuticals, Avedro, IFM Therapeutics, Virion Biotherapeutics, Realm Therapeutics, Pixium Vision, . Over time, Bali Muralidhar has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bali Muralidhar is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Autoimmune Diseases, Wellness, Women Founded, Fundraising, Investment Management, Strategic Partnerships, Life Science, Portfolio Management, Finance, Biotechnology, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Gene Therapy, Vaccines, UK-based Startups, Regulatory Compliance, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Bali Muralidhar, as their portfolio suggests a familiarity and interest in this area.

Understanding Bali Muralidhar’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.